United States v. VASCULAR ACCESS CENTERS, LLC

CourtDistrict Court, W.D. Pennsylvania
DecidedJune 20, 2024
Docket2:19-cv-01524
StatusUnknown

This text of United States v. VASCULAR ACCESS CENTERS, LLC (United States v. VASCULAR ACCESS CENTERS, LLC) is published on Counsel Stack Legal Research, covering District Court, W.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. VASCULAR ACCESS CENTERS, LLC, (W.D. Pa. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF PENNSYLVANIA

UNITED STATES, ex rel., ) DAVID W, STEBBINS, ) ) Plaintiff/Relator ) ) v. ) Civil No. 19-1524 ) VASCULAR ACCESS CENTERS, LLC, ) VASCULAR ACCESS CENTER OF ) PITTSBURGH, PHILADELPHIA ) VASCULAR INSTITUTE, LLC, MAIN ) LINE VASCULAR INSTITUTE, LLC, ) VASCULAR ACCESS CENTER OF ) MAINLINE, LLC, PERIPHERAL ) VASCULAR INSTITUTE OF ) PHILADELPHIA, LLC, and ) JAMES F. MCGUCKIN, ) ) Defendants. ) ) ) Opinion Relator David W. Stebbins commenced this qui tam action pursuant to the federal False Claims Act (FCA), 31 U.S.C. §§ 3729, et seq., against Defendants Vascular Access Centers, LLC, Vascular Access Center of Pittsburgh, LLC, Philadelphia Vascular Institute, LLC, Main Line Vascular Institute, LLC, Vascular Access Center of Mainline, LLC, Peripheral Vascular Institute of Philadelphia, LLC and James F. McGuckin. The Relator alleges that Defendants submitted false claims for payment to the Medicare and Medicaid programs arising from procedures performed in their own, improperly licensed, facilities, instead of in properly state- licensed Ambulatory Surgical Facilities, in violation of the False Claims Act. 31 U.S.C. §§ 3729(a)(1)(A) and 3729(a)(1)(B). Presently before the Court is the Motion to Dismiss the Second Amended Complaint filed by Defendants Vascular Access Centers, LLC, Philadelphia Vascular Institute, LLC, Main Line Vascular Institute, LLC, Vascular Access Center of Mainline, LLC, Peripheral Vascular Institute of Philadelphia, LLC, and Dr. James F. McGuckin.1 ECF No. 39. Relator has filed a Response in Opposition, to which the Defendants have filed a Reply. ECF No. 43 and 44. For the reasons

explained below, Defendants’ Motion to Dismiss will be denied in part, granted in part, and Relator will be given leave to file an amended complaint. I. Background A. Parties Defendant James F. McGuckin, M.D. is a vascular and interventional radiologist, and is the owner, founder, principal, and a general partner of non-party Vascular Access Centers, L.P. (non-party VAC). Defendant Vascular Access Centers, LLC, is a general partner of non-party VAC. Dr. McGuckin, and/or non-party VAC, had a controlling ownership interest in the remaining Defendants: Philadelphia Vascular Institute, LLC, Main Line Vascular Institute, LLC,

Vascular Access Center of Mainline, LLC, and Peripheral Vascular Institute of Philadelphia, LLC. Relator David W. Stebbins was employed by non-party VAC, from June 2006 through October 2018, as its Administrative Director. B. Relevant Procedural History The initial Complaint in this matter was filed on November 25, 2019. ECF No. 1. Two months later, Relator filed an Amended Complaint. ECF No. 2. Both complaints were filed under seal, and not served upon the Defendants, pursuant to the False Claims Act. 31 U.S.C. §

1 The Court will refer to the six Defendants who have filed the present Motion to Dismiss as “Defendants.” The docket does not reflect that Defendant Vascular Access Center of Pittsburgh, LLC (VAC-PGH) has been served, nor has VAC-PGH filed an Answer or a Motion to Dismiss. 3730(b)(2). Armed with “the complaint and written disclosure of substantially all material evidence and information the [relator] possesses,” the government is given an initial 60-day period to investigate the relator’s claims and to decide whether to intervene in the matter. Id. Pursuant to section 3730(b)(3), the government may seek an extension of time to investigate the allegations, while the Complaint continues to remain under seal. 31 U.S.C. § 3730(b)(3). When

the government’s investigation has concluded, the government shall inform the Court whether it will “(A) proceed with the action, in which case the action shall be conducted by the Government; or (B) notify the court that it declines to take over the action, in which case the person bringing the action shall have the right to conduct the action.” 31 U.S.C. § 3730(b)(4). In either case, once the government makes its decision, the complaint is unsealed and the matter proceeds with the complaint being served upon the defendant. Here, the government sought eight extensions of time to investigate Relator’s allegations through May 8, 2023, at which time it informed the Court of its decision not to intervene in this action. ECF No. 26. The case was unsealed on May 9, 2023, and, pursuant to a stipulation with

Defendants, Relator filed a Second Amended Complaint on September 1, 2023. ECF No. 33. Thereafter, Defendants filed their Motion to Dismiss, to which Relator filed his Response. ECF Nos. 39, 43. Defendants filed a Reply to Relator’s Response, and later filed a Notice of Supplemental Authority. ECF Nos. 44, 45. C. Allegations The Second Amended Complaint asserts two causes of action. Count One alleges that Defendants knowingly presented, or caused to be presented, false claims for payment to the government. 31 U.S.C. § 3729(a)(1)(A). Count Two alleges that Defendants knowingly made, used, or caused to be made or used, false records and statements that were material to their false claims. 31 U.S.C. § 3729(a)(1)(B). Relator specifically alleges that Defendants created and submitted Forms CMS-855I and CMS-1500, both of which included false representations and certifications and which also failed to disclose material information. Relator alleges that the Defendants submitted false claims to Medicare and Medicaid, either directly or through their agents, employees, and contractors, for reimbursement for

performing arteriograms and related intravascular ultrasound procedures. Performing an arteriogram, or a related procedure, requires the administration of anesthesia exceeding local or topical anesthesia. Administration of such anesthesia, such as general anesthesia, obtunds or dulls or deadens, the reflexes of patients. Relator alleges that Defendants performed the medical procedures in out-patient facilities that did not comply with Pennsylvania State Department of Health regulations regarding the administration of anesthesia. Specifically, pursuant to the “Definitions” section of the Pennsylvania Department of Health regulations, surgical procedures, that involve the administration of such anesthesia exceeding local or topical anesthesia, are to be provided only at acute care hospitals or Class B or Class C Ambulatory Surgical Facilities. 28

Pa. Code § 551.3 (Definitions). Relator claims that, because Defendants did not perform the medical procedures at an acute care hospital or at a Class B or Class C Ambulatory Surgical Facility, any claim, knowingly submitted for payment to Medicare or Medicaid, is a false claim. Relator alleges that the falsity of the claims arises from the failure of Defendants to disclose to the government that the arteriograms and related medical procedures, for which they submitted claims, had been performed at facilities that were not properly licensed under Pennsylvania Department of Health regulations. The falsity of the claims also arises from the Defendants’ failure to inform their patients that the procedures were going to be performed in violation of Pennsylvania Department of Health regulations.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States Ex Rel. Grubbs v. Kanneganti
565 F.3d 180 (Fifth Circuit, 2009)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Phillips v. County of Allegheny
515 F.3d 224 (Third Circuit, 2008)
Elias Eid v. John Thompson
740 F.3d 118 (Third Circuit, 2014)
Patricia Thompson v. Real Estate Mortgage Network
748 F.3d 142 (Third Circuit, 2014)
Thomas Foglia v. Renal Ventures Management
754 F.3d 153 (Third Circuit, 2014)
Alan Schmidt v. John Skolas
770 F.3d 241 (Third Circuit, 2014)
Junius Construction Corp. v. Cohen
178 N.E. 672 (New York Court of Appeals, 1931)
United States v. Sanford-Brown, Limited
840 F.3d 445 (Seventh Circuit, 2016)
United States Ex Rel. Petratos v. Genentech Inc.
855 F.3d 481 (Third Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. VASCULAR ACCESS CENTERS, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-vascular-access-centers-llc-pawd-2024.